BOT vs RAD

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BOT

BOTANIX FPO [BOT]

39LOW

RAD

RADIOPHARM FPO [RAD]

40LOW

Score Breakdown

BOT RAD
Technical
47
55
Catalyst
51
53
Sentiment
50
50
Fundamental
76
76
Momentum
29
45
Risk Gate
45
37

Key Metrics

BOT Metric RAD
$70.7MMarket Cap$47.3M
14.5MAvg Volume (20d)4.5M
+0.2%Short Interest+0.0%
$0.18052-Week High$0.040
$0.01852-Week Low$0.017
+0.0%Daily Change+0.0%
$0.025Reference Price$0.020
-121.1%ROE-92.1%
N/AProfit Margin-286.2%

Active Signals

BOT Signals

●Stochastic is stretched into overbought — could need a breather
●Beating the Small Ords index — relative strength of 1.17, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Low P/S ratio (3.2x)
●Strong revenue growth (+4271%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (5% of range)

RAD Signals

●MACD momentum is picking up steam
●Above-average volume (1.5x) on a green day — buyers stepping up
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Low P/S ratio (2.9x)
●Strong revenue growth (+154%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare BOT and RAD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BOT vs REG →CAN vs DXB →CAN vs MSB →CAN vs PKP →CAN vs PYC →
BOT Full Analysis → RAD Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).